期刊
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
卷 44, 期 7, 页码 1393-1399出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2004.06.068
关键词
-
OBJECTIVES We sought to develop a simple risk score of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI). BACKGROUND Although several risk factors for CIN have been identified, the cumulative risk rendered by their combination is unknown. METHODS A total of 8,357 patients were randomly assigned to a development and a validation dataset. The baseline clinical and procedural characteristics of the 5,571 patients in the development dataset were considered as candidate univariate predictors of CIN (increase greater than or equal to25% and/or 0.5 mg/dl in serum creatinine at 48 h after PCI vs. baseline). Multivariate logistic regression was then used to identify independent predictors of CIN with a p value <0.0001. Based on the odds ratio, eight identified variables (hypotension, intra-aortic balloon pump, congestive heart failure, chronic kidney disease, diabetes, age >75 years, anemia, and volume of contrast) were assigned a weighted integer; the sum of the integers was a total risk score for each patient. RESULTS The overall occurrence of CIN in the development set was 13.1% (range 7.5% to 57.3% for a low [less than or equal to5] and high [greater than or equal to16] risk score, respectively); the rate of CIN increased exponentially with increasing risk score (Cochran Armitage chi-square, p < 0.0001). In the 2,786 patients of the validation dataset, the model demonstrated good discriminative power (c statistic = 0.67); the increasing risk score was again strongly associated with CIN (range 8.4% to 55.9% for a low and high risk score, respectively). CONCLUSIONS The risk of CIN after PCI can be simply assessed using readily available information. This risk score can be used for both clinical and investigational purposes. (J Am Coll Cardiol 2004;44:1393-9) (C) 2004 by the American College of Cardiology Foundation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据